Interactive Session:
30. HIV Interactive
Thursday, October 3, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: Esplanade Ballroom 301-310

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify complicating variables in HIV cases
  • apply HIV treatment strategies to complicated variables in a case study
  • identify alternate treatment strategies for HIV

Target Audience: researchers, public health practitioners, members-in-training, infectious diseases physicians, HIV specialists, HIV clinicians, fellows, clinicians

Tracks: HIV-STD-TB

Interactive Moderators:  Paul Sax, MD, FIDSA, Brigham and Women's Hospital and Paul Volberding, MD, FIDSA, University of California San Francisco

Presentations:

10:30 AM
99
Interactive Panelist
Judith Currier, MD, MSc

10:50 AM
100
Interactive Panelist
Edwin Dejesus, MD, FACP. FIDSA

11:10 AM
101
Interactive Panelist
Joseph J. Eron, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 application-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-101-L02-P

Disclosures:

P. Sax, BMS: Investigator and Scientific Advisor, Grant recipient and Salary
Gilead: Investigator and Scientific Advisor, Research grant and Salary
Janssen: Scientific Advisor, Salary
Merck: Scientific Advisor, Salary
GSK: Investigator and Scientific Advisor, Grant recipient and Salary

P. Volberding, BMS: Scientific Advisor, Consulting fee
Gilead: Scientific Advisor, Consulting fee

J. Currier, Gilead: Consultant, Consulting fee
Viiv: Consultant, Consulting fee
Serono: Collaborator, Consulting fee
Merck and Company: Grant Investigator, Research grant

E. Dejesus, Gilead Science: Board Member, Consultant, Investigator and Speaker's Bureau, Consulting fee, Research support and Speaker honorarium
Janssen: Board Member, Consultant, Investigator and Speaker's Bureau, Consulting fee and Research support
Merck : Investigator, Research support
Glaxo SmithKline: Investigator, Research support
Bristol-Meyer Squibb: Investigator, Research support

J. J. Eron, Merck: Consultant and Investigator, Consulting fee and Research Grant to UNC School of Medicine (completed)
GSK: Consultant and Investigator, Consulting fee, Research grant and Research Grant to UNC School of Medicine
ViiV: Consultant, Consulting fee
BMS: Consultant, Consulting fee and Grant to UNC School of Medicine
Gilead: Consultant, Consulting fee
Janssen: Consultant, Consulting fee

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.